| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8525396 | Biomedicine & Pharmacotherapy | 2018 | 9 Pages |
Abstract
Overall, it was concluded that NSAIDs, particularly cyclooxygenase-2 (COX-2) inhibitors, might have a protective effect on CRC development and slow down progression of tumor in a DMH-induced experimental cancer model. One of the possible mechanisms in the chemoprevention of colon cancer seems to be inhibition of angiogenesis by diclofenac and celecoxib.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Hilal Gungor, Nevin Ilhan, Hatice Eroksuz,